Benzinga’s Top Pre-Market Losers (PARD, DLTR, GENZ, SNDA, ACOR, TTHI, HCBK)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) decreased $0.33 or 12.64% to $2.28 in the pre-market session. Poniard Pharmaceuticals announced yesterday final data from a randomized , controlled Phase 2 trial of picoplatin in metastatic colorectal cancer patients. The 52-week trading range for PARD is $1.50 - $9.14. Poniard Pharmaceuticals has declined over 64% in the last six months.

Dollar Tree, Inc. (NASDAQ: DLTR) tumbled 2.49% to $47.02 in the pre-market session. Dollar Tree closed at $48.22 in the last trading session. The 52-week trading range for DLTR is $32.94 - $52.20. DLTR has surged over 6% in the last six months.

Genzyme Corporation (NASDAQ: GENZ) declined 1.80% to $53.40 in the pre-market session. The 52-week trading range for GENZ is $47.09 - $73.75. GENZ has declined over 19% in the last year. Genzyme Corporation closed at $54.38 in the last trading session.

Shanda Interactive Entertainment Ltd ADR (NASDAQ: SNDA) plunged 2.91% to $48.01 in the pre-market session. Shanda Interactive Entertainment closed at $49.45 in the last trading session. In the last six months, SNDA has declined over 13%. The 52-week trading range for SNDA is $26.70 - $65.00.

Acorda Therapeutics Inc. (NASDAQ: ACOR) fell 1.10% to $27.81 after Acorda Therapeutics announced today that Lauren Sabella has joined ACOR as Executive Vice President, Commercial Development, reporting to Ron Cohen, M.D., President and Chief Executive Officer. Ms. Sabella will have responsibility for Acorda’s commercial operations, including Marketing, Sales and Managed Markets. The 52-week trading range for is $15.52 - $29.36. Acorda Therapeutics has gained over 6% in the last six months.

Transition Therapeutics Inc. (NASDAQ: TTHI) declined 2.08% to $3.30 after Transition Therapeutics announced the results from a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Transition Therapeutics closed at $3.37 in the last trading session. The 52-week trading range for TTHI is $3.28 - $9.00. In the last year, TTHI has declined by 14%.

Hudson City Bancorp, Inc. (NASDAQ: HCBK) decline 0.84% to $13.01 in the pre-market session. The 52-week trading range for HCBK is $7.46 - $14.77. Hudson City Bancorp closed at $13.12 in the last trading session. In the last year, HCBK has gained over 9%.